ABL1 monoclonal antibody, clone 7B11D6 供应商 Abnova 产品货号 MAB17689 产品报价 ¥询价/100uL 产品说明书 点击查看 购买方式 在线支付宝及网银支付、支票、现金、电汇,或拨打全国免费服务电话4006800868与我们联系。 产品新闻 背景资料 待更新 应用类型 ...
bcr-abl monoclonal antibody (7c6) 高级验证 this antibody was verified by knockout to ensure that the antibody binds to the antigen stated. 1个已发表图片 1篇参考文献 货号 ma1-153 100µg cny 5,601.00 查看价格 下单后预计发货日期 28-aug-2024 数量 批量或定制请求 添加到购物车 保存到列表 ...
ABL2 monoclonal antibody (M06), clone 2H8, H00000027-M06, highly specific and rigorously validated in-house for Western Blot (WB), ELISA (ELISA). Reacts with Human.ABL2 monoclonal antibody (M06), clone 2H8, H00000027-M06 is ready to ship.
EPT-A-6149-100 Epigentek RPS6KB1 Monoclonal Antibody [1E12] (100 µg) EPT-A-6150-100 Epigentek RPS6KB2 Monoclonal Antibody [4B11] (100 µg) EPT-A-6151-100 Epigentek ASF1B Monoclonal Antibody [4D5-2C2] (100 µg) EPT-A-6152-100 Epigentek DDIT3 Monoclonal Antibody [2G3] ...
c-abl monoclonal antibody (7b11d6) 查看其他40个c-abl抗体 货号 ma5-15430 100µl cny 4,906.00 查看价格 下单后预计发货日期 09-sep-2024 数量 批量或定制请求 添加到购物车 保存到列表 性能保障 说明书 实验方案 技术支持 抗体检测数据 (1) application 图: 1 / 1 c-abl antibody (ma5-15430) ...
1:200-1:1,000 - 酶联免疫吸附实验 (ELISA) 1:10,000 - 产品规格 种属反应 Human, Mouse 宿主/亚型 Mouse / IgG1 分类 Monoclonal 类型 Antibody 克隆号 1H1 抗原 Purified recombinant fragment of ABL2 expressed in E. Coli. 偶联物 Unconjugated 形式 Liquid 浓度 Conc. Not...
5 µL (0.125 µg)/test - 产品规格 种属反应 Human 宿主/亚型 Mouse / IgG1, kappa 推荐的同型对照 Mouse IgG1 kappa Isotype Control (P3.6.2.8.1), PE, eBioscience™ 分类 Monoclonal 类型 Antibody 克隆号 KOR-SA3544 偶联物 PE
monoclonal antibody— 单克隆抗体 巨球形 ▾ 外部资源(未审查的) Its most advanced program is MOR103, a first-in-class,fully human antibodyagainst GM-CSF. wacker.com wacker.com 其进展最大的计划是MOR103, 这是一个治疗细胞因子GM-CSF的完整人类抗体。
(R&D Systems) | seven hills bioreagents | zytovision | zyagen Laboratories | ZeptoMetrix | WSU Monoclonal Antibody Center | VMRD | VitaNavi | Virusys | Usbiological | UBPBIO | tulip biolabs | TriLink BioTechnologies | TRC | Ted Pella | swant | steraloids | ST john's laboratory | Sphero...
The use of immunotherapy in the treatment of cancers has been accelerating and increasing evidence has shown that antibody therapies can improve the outcome of patients with cancer9,10. Rituximab, a chimeric murine/human anti-CD20 monoclonal IgG1κ antibody targeting B cells, is currently indicated...